Shuttle Pharmaceuticals Holdings (SHPH) Income Statement: Revenue & Earnings

Shuttle Pharmaceuticals Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Shuttle Pharmaceuticals Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	3.62	3.52	1.15	1.02	0.16
Selling, General & Administrative	4.08	2.38	1.41	0.72	0.35
Operating Expenses	7.70	5.89	2.55	1.74	0.51
Operating Income	-7.70	-5.89	-2.55	-1.74	-0.51
Other Income/Expense
Interest Income	0.04	0.08	0.00	0.00	0.00
Interest Expense	1.36	-2.49	-0.97	0.05	-0.04
Other Income/Expense	-0.13	2.11	0.09	0.64	-0.26
Income
Income Before Tax	-9.14	-6.59	-3.03	-1.15	-0.81
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-9.14	-6.59	-3.03	-1.15	-0.81
Net Income - Continuous Operations	-9.14	-6.59	-5.00	-1.15	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-7.78	-5.89	-2.55	-1.04	-0.50
EBIT	-7.78	-5.89	-2.55	-1.10	-0.51
Depreciation & Amortization	0.01	0.01	0.01	0.06	0.01
Earnings Per Share
Basic EPS	-80.00	-88.00	-60.00	-19.00	-20.00
Diluted EPS	-82.00	-88.00	-60.00	-19.00	-20.00
Basic Shares Outstanding	0.11	0.07	0.05	0.07	0.05
Diluted Shares Outstanding	0.12	0.07	0.05	0.07	0.05